InflaRx IFRX
NASDAQ IFRX
$2.10 +0.08 (+3.96%)
At close: Aug 21, 2026 · 4:00 PM EDT

InflaRx (IFRX) Shares Outstanding (Diluted) (2016 - 2026)

InflaRx (IFRX) Shares Outstanding (Diluted) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 64.41 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 398.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 115.80 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 138.28 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 241.70 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 217.35 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 556.90 Mn
10 InflaRx 140.30 Mn -43.96 Mn 2.74 Bn 117.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 72.29 Mn
Dec 31, 2025 67.29 Mn
Sep 30, 2025 67.75 Mn
Jun 30, 2025 67.75 Mn
Mar 31, 2025 63.31 Mn
Dec 31, 2024 58.92 Mn
Sep 30, 2024 58.88 Mn
Jun 30, 2024 58.88 Mn
Mar 31, 2024 58.88 Mn
Dec 31, 2023 54.94 Mn
Sep 30, 2023 58.88 Mn
Jun 30, 2023 56.99 Mn
Mar 31, 2023 44.77 Mn
Dec 31, 2022 44.21 Mn
Sep 30, 2022 44.20 Mn
Jun 30, 2022 44.20 Mn
Mar 31, 2022 44.20 Mn
Dec 31, 2021 41.63 Mn
Sep 30, 2021 44.19 Mn
Jun 30, 2021 44.19 Mn